Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences
Matthew L Stoll, Alisa C GotteDepartment of Pediatrics, Division of Rheumatology, UT Southwestern Medical Center, Dallas, TX, USAAbstract: Biologics have advanced the therapy of adult and pediatric arthritis. They have been linked to rare serious adverse outcomes, but the actual risk of these events...
Guardado en:
Autores principales: | Matthew L Stoll, Alisa C Gotte |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95739b8c0040412b8576486b3028f6c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature
por: Alisa Carman Gotte
Publicado: (2009) -
Persistence and adherence to biologic therapies in juvenile idiopathic arthritis
por: Juan Carlos Nieto-González, et al.
Publicado: (2021) -
Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
por: Murakami M, et al.
Publicado: (2012) -
Psycho-emotional condition of young adults with juvenile idiopathic arthritis
por: M.B. Dzhus
Publicado: (2017) -
MRI Findings in Hip in Juvenile Idiopathic Arthritis
por: Monika Ostrowska, et al.
Publicado: (2021)